Increased iNOS expression and changes in NO levels are not only characteristic of malignancies of the thyroid gland but also various other malignancies associated with inflammation (62), such as lung cancer (63), colorectal cancer (64), breast cancer (65) pancreatic cancer (66) and laryngeal cancer and melanoma (67). Here, NOS2 is linked to laryngeal carcinoma.